Earnings Call · Q3 FY2025·2025-11-06

Q3 25EPS +3.14%·Rev n/aQ2 25EPS +16.42%·Rev n/aQ1 25EPS 0.00%·Rev n/aQ4 24EPS -7.33%·Rev n/a⚠ consensus missing

CYTOKINETICS INC CYTK

Diane Weiser — Senior Vice President of Corporate

Robert I. Blum — President and Chief Executive Officer

Andrew Callos — Executive Vice President and Chief Commercial Officer

Fady Malik — Executive, likely clinical or medical affairs

Stuart Kupfer — Executive, likely clinical development or medical affairs

Sung Lee — Executive, likely Chief Financial Officer or similar

+1.9%1d on move date+2.9% vs SPY3d+5.1%5d+11.4%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CYTK calls or request research access.

More CYTK calls Browse calls Request research access